PACRG anticorps (Middle Region)
Aperçu rapide pour PACRG anticorps (Middle Region) (ABIN631123)
Antigène
Voir toutes PACRG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- PACRG antibody was raised against the middle region of PACRG
-
Purification
- Affinity purified
-
Immunogène
- PACRG antibody was raised using the middle region of PACRG corresponding to a region with amino acids GAIMARCNLDHLGSSDPPTSASQVAEIIVNSGDGIDYSQQKRENIGDLIQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PACRG Blocking Peptide, (ABIN938543), is also available for use as a blocking control in assays to test for specificity of this PACRG antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PACRG antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PACRG (PARK2 Co-Regulated (PACRG))
-
Autre désignation
- PACRG
-
Sujet
- PACRG is a protein that is conserved across metazoans. In vertebrates, this gene is linked in a head-to-head arrangement with the adjacent parkin gene, which is associated with autosomal recessive juvenile Parkinson's disease. These genes are co-regulated in various tissues and they share a bi-directional promoter. Both genes are associated with susceptibility to leprosy.
-
Poids moléculaire
- 33 kDa (MW of target protein)
Antigène
-